JianGuanMD
Internal Medicine • Houston, TXHematology/Oncology
Active Member of Houston Methodist Neal Cancer Center
Dr. Guan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18220 State Highway 249 Ste 100
Houston, TX 77070Phone+1 281-737-0435
Education & Training
Methodist Hospital (Houston)Fellowship, Hematology and Medical Oncology, 2021 - 2024
AdventHealth Florida (Orlando)Residency, Internal Medicine, 2015 - 2018
Boston University School of MedicinePhD, Molecular Medicine , 2006 - 2012
Tongji Medical UniversityClass of 2002
Certifications & Licensure
TX State Medical License 2021 - 2025
FL State Medical License 2015 - 2022- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Chief Fellow Houston Methodist Hospital, Hematology/Oncology Fellowship, 2023
- Research Mentor Award Adventhealth Orlando Graduate Medical Education, 2021
- First place in Academic Debate American Liver Foundation (Southeastern Division), 2019
- Join now to see all
Clinical Trials
- Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer Start of enrollment: 2020 Mar 03
- SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC Start of enrollment: 2017 Jul 01
- Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy Start of enrollment: 2021 Oct 14
Publications & Presentations
PubMed
- 3 citationsNeighborhood Walkability Is Associated With Lower Burden of Cardiovascular Risk Factors Among Cancer Patients.Nwabunie Nwana, Omar Mohamed Makram, Juan C Nicolas, Alan Pan, Rakesh Gullapelli
JACC. Cardiooncology. 2024-06-01 - 3 citationsA Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.Jian Guan, Kai Sun, Carlo A Guerrero, Junjun Zheng, Yitian Xu
International Journal of Radiation Oncology, Biology, Physics. 2024-04-01 - 7 citationsA Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors.Mengni Guo, Jieying Liu, Ruoyu Miao, Zohaib Ahmed, James Yu
Journal of Immunotherapy. 2022-09-05
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
